1.63
Ocugen Inc Aktie (OCGN) Neueste Nachrichten
Will Ocugen Inc. stock maintain dividend yieldTrade Volume Summary & Consistent Profit Alerts - newser.com
Can Ocugen Inc. (2H51) stock sustain double digit ROE2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
Ocugen Inc. stock prediction for this weekTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Combining price and volume data for Ocugen Inc.Long Setup & Free Growth Oriented Trading Recommendations - newser.com
How Ocugen Inc. stock reacts to job market dataWeekly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Signal strength of Ocugen Inc. stock in tech scannersWall Street Watch & Intraday High Probability Alerts - newser.com
Ocugen Stock Shock: What’s Next? - StocksToTrade
Best data tools to analyze Ocugen Inc. stockQuarterly Trade Review & Community Consensus Trade Alerts - newser.com
Tools to assess Ocugen Inc.’s risk profileMarket Volume Report & Safe Entry Point Alerts - newser.com
Ocugen (NASDAQ:OCGN) Shares Down 7.4%Should You Sell? - MarketBeat
Ocugen Inc. Stock Falls Friday, Underperforms Market - 富途牛牛
Will Ocugen Inc. stock outperform international peers2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Exit strategy if you’re trapped in Ocugen Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Ocugen (NASDAQ:OCGN) - MarketBeat
What data driven models say about Ocugen Inc.’s futureWeekly Trading Summary & Community Verified Trade Signals - newser.com
How Ocugen Inc. (2H51) stock moves on employment data2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
A activityJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Will earnings trigger a reversal in Ocugen Inc.Market Growth Review & Free Reliable Trade Execution Plans - newser.com
Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss - MSN
Ocugen, Inc. Hits New 52-Week High of $1.90, Marking Major Milestone - Markets Mojo
Ocugen to Highlight Gene Therapy Pipeline at Key Industry and Investor Conferences - MyChesCo
Published on: 2025-10-06 02:02:01 - newser.com
Automated trading signals detected on Ocugen Inc.Market Rally & Weekly Breakout Opportunity Watchlist - newser.com
Analyzing recovery setups for Ocugen Inc. investorsJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Real time pattern detection on Ocugen Inc. stockFed Meeting & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:08:53 - newser.com
What drives Ocugen Inc 2H51 stock priceBull Market Opportunities & Explosive Growth Opportunities - earlytimes.in
Is Ocugen Inc 2H51 a good long term investmentPrice Volatility Patterns & You’ll Regret Not Buying These Early - earlytimes.in
Ocugen (NASDAQ:OCGN) Hits New 52-Week HighHere's Why - MarketBeat
Published on: 2025-10-03 06:57:10 - newser.com
Regression analysis insights on Ocugen Inc. performanceTrade Volume Report & Low Risk High Reward Ideas - newser.com
How to recover losses in Ocugen Inc. stockGap Down & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-03 02:54:41 - newser.com
Ocugen, Inc. to Present at NobleCon20 Emerging Growth Equity Conference - MSN
Ocugen to Present at Major Biotechnology Conferences Focused on Advancements in Gene Therapies for Blindness Diseases - Quiver Quantitative
Ocugen to Present at Industry and Investor Conferences in October 2025 - GlobeNewswire
Targeting 3 BLA Submissions: Ocugen Leadership to Present Gene Therapy Vision at Major Industry Events - Stock Titan
Traders Buy High Volume of Ocugen Call Options (NASDAQ:OCGN) - MarketBeat
Ocugen Inc Stock Analysis and ForecastInsider Selling Patterns & High Return Capital Gains - earlytimes.in
Ocugen Strikes $7.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):